Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter

ABBOTT PARK, Ill., May 3, 2018 — Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance of the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™. Advisor HD Grid employs a new design that allows physicians to see things differently, capturing and analyzing data in a novel manner to create highly detailed maps of the heart that better differentiate healthy from unhealthy tissue.

Boosting user acceptance could improve utilization of clinical decision support tools

Roxana Mehran, MD, of Mount Sinai Hospital in New York City, takes charge during a procedure.

Clinical decision support systems (CDSSs) have shown potential in reducing medical errors and improving patient outcomes, but utilization remains low due to a lack of user acceptance, according to a study published April 18 in JMIR Medical Informatics.